Biblio
Export 215 results:
[ Author
Filters: First Letter Of Last Name is M [Clear All Filters]
“Homocysteine, Infections, Polyamines, Oxidative Metabolism, and the Pathogenesis of Dementia and Atherosclerosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1283-1290, 2016.
, “Aerosol Delivery of Curcumin Reduced Amyloid-β Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 797-811, 2017.
, “Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1537-1547, 2022.
, “Visual Processing of Emotional Faces is Preserved in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 1, pp. 397-405, 2018.
, “Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1495-1508, 2016.
, “Oxygen and Glucose Deprivation Alter Synaptic Distribution of Tau Protein: The Role of Phosphorylation.”, J Alzheimers Dis, vol. 60, no. 2, pp. 593-604, 2017.
, “Age-Related Effects of the Apolipoprotein E Gene on Brain Function.”, J Alzheimers Dis, vol. 52, no. 1, pp. 317-31, 2016.
, “Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS).”, J Alzheimers Dis, vol. 46, no. 3, pp. 687-93, 2015.
, “Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer's Disease and Cognitive Function.”, J Alzheimers Dis, vol. 84, no. 2, pp. 787-796, 2021.
, “Neural Correlates of Sleep Disturbance in Alzheimer's Disease: Role of the Precuneus in Sleep Disturbance.”, J Alzheimers Dis, vol. 63, no. 3, pp. 957-964, 2018.
, “Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1229-1239, 2017.
, “Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.”, J Alzheimers Dis, vol. 54, no. 2, pp. 635-43, 2016.
, “Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AβPPswe/PSEN1dE9 Alzheimer's Disease Model Mice Fed a High-Fat Diet.”, J Alzheimers Dis, vol. 56, no. 1, pp. 1-23, 2017.
, “Diabetes is Not Associated with Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1035-1043, 2017.
, “Validation of the Spanish Version of the LASSI-L for Diagnosing Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 2, pp. 733-742, 2017.
, “Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 78, no. 2, pp. 537-541, 2020.
, “Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 103-111, 2018.
, “Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 2, pp. 743-752, 2022.
, “Altered microRNA, mRNA, and Protein Expression of Neurodegeneration-Related Biomarkers and Their Transcriptional and Epigenetic Modifiers in a Human Tau Transgenic Mouse Model in Response to Developmental Lead Exposure.”, J Alzheimers Dis, vol. 63, no. 1, pp. 273-282, 2018.
, “Early-Life Exposure to Lead (Pb) Alters the Expression of microRNA that Target Proteins Associated with Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1257-64, 2016.
, “Family History of Alzheimer's Disease is Associated with Impaired Perceptual Discrimination of Novel Objects.”, J Alzheimers Dis, vol. 57, no. 3, pp. 735-745, 2017.
, “Multisensory Stimulation and Individualized Music Sessions on Older Adults with Severe Dementia: Effects on Mood, Behavior, and Biomedical Parameters.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1415-1425, 2018.
, “Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation.”, J Alzheimers Dis, vol. 57, no. 3, pp. 907-925, 2017.
, “Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.”, J Alzheimers Dis, vol. 54, no. 1, pp. 307-24, 2016.
, “Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 915-932, 2017.
,